{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:55:39Z","timestamp":1780880139684,"version":"3.54.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Valproic acid (VPA) stands as one of the most frequently prescribed medications in children with newly diagnosed epilepsy. Despite its infrequent adverse effects within therapeutic range, prolonged VPA usage may result in metabolic disturbances including insulin resistance and dyslipidemia. These metabolic dysregulations in childhood are notably linked to heightened cardiovascular risk in adulthood. Therefore, identification and effective management of dyslipidemia in children hold paramount significance.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In this retrospective cohort study, we explored the potential associations between physiological factors, medication situation, biochemical parameters before the first dose of VPA (baseline) and VPA-induced dyslipidemia (VID) in pediatric patients. Binary logistic regression was utilized to construct a predictive model for blood lipid disorders, aiming to identify independent pre-treatment risk factors. Additionally, The Receiver Operating Characteristic (ROC) curve was used to evaluate the performance of the model.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Through binary logistic regression analysis, we identified for the first time that direct bilirubin (DBIL) (odds ratios (OR) = 0.511, <jats:italic>p<\/jats:italic> = 0.01), duration of medication (OR = 0.357, <jats:italic>p<\/jats:italic> = 0.009), serum albumin (ALB) (OR = 0.913, <jats:italic>p<\/jats:italic> = 0.043), BMI (OR = 1.140, <jats:italic>p<\/jats:italic> = 0.045), and aspartate aminotransferase (AST) (OR = 1.038, <jats:italic>p<\/jats:italic> = 0.026) at baseline were independent risk factors for VID in pediatric patients with epilepsy. Notably, the predictive ability of DBIL (AUC = 0.690, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001) surpassed that of other individual factors. Furthermore, when combined into a predictive model, incorporating all five risk factors, the predictive capacity significantly increased (AUC = 0.777, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001), enabling the forecast of 77.7% of dyslipidemia events.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> DBIL emerges as the most potent predictor, and in conjunction with the other four factors, can effectively forecast VID in pediatric patients with epilepsy. This insight can guide the formulation of individualized strategies for the clinical administration of VPA in children.<\/jats:p>","DOI":"10.3389\/fphar.2024.1349043","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T05:26:28Z","timestamp":1712035588000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy"],"prefix":"10.3389","volume":"15","author":[{"given":"Tiantian","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenquan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuli","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimeng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5607349","DOI":"10.1155\/2018\/5607349","article-title":"The correlation of dyslipidemia with the extent of coronary artery disease in the multiethnic study of atherosclerosis","volume":"2018","author":"Abd Alamir","year":"2018","journal-title":"J. Lipids"},{"key":"B2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3945\/an.113.005447","article-title":"Coronary heart disease risk factors in college students","volume":"5","author":"Arts","year":"2014","journal-title":"Adv. Nutr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ejpn.2006.09.002","article-title":"Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study","volume":"10","author":"Attilakos","year":"2006","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1210\/jc.2013-3860","article-title":"Update on screening, etiology, and treatment of dyslipidemia in children","volume":"99","author":"Bamba","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2013.08.016","article-title":"Metabolic and endocrine effects of valproic acid chronic treatment","volume":"107","author":"Belcastro","year":"2013","journal-title":"Epilepsy Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.31083\/j.rcm2203088","article-title":"Dyslipidemia in pediatrician's practice","volume":"22","author":"Burlutskaya","year":"2021","journal-title":"Rev. Cardiovasc Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/MNH.0000000000000788","article-title":"Contemporary risk prediction models in chronic kidney disease: when less is more","volume":"31","author":"Canney","year":"2022","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B9","doi-asserted-by":"publisher","first-page":"s18","DOI":"10.2450\/2013.005s","article-title":"Clinical use of albumin","volume":"11","author":"Caraceni","year":"2013","journal-title":"Blood Transfus."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/pharmaceutics13081208","article-title":"The effect of plasma protein binding on the therapeutic monitoring of antiseizure medications","volume":"13","author":"Charlier","year":"2021","journal-title":"Pharmaceutics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2217\/pgs.12.78","article-title":"Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid","volume":"13","author":"Chatzistefanidis","year":"2012","journal-title":"Pharmacogenomics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11894-021-00813-6","article-title":"Overview of albumin physiology and its role in pediatric diseases","volume":"23","author":"Chen","year":"2021","journal-title":"Curr. Gastroenterol. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1393","DOI":"10.1212\/WNL.0000000000200912","article-title":"Mortality, disability, and prognostic factors of status epilepticus: a nationwide population-based retrospective cohort study","volume":"99","author":"Choi","year":"2022","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/0004563216657841","article-title":"Analbuminaemia: clinical features and associated hypercholesterolaemia","volume":"53","author":"Crook","year":"2016","journal-title":"Ann. Clin. Biochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.12998\/wjcc.v1.i1.44","article-title":"Treatment of a patient with congenital analbuminemia with atorvastatin and albumin infusion","volume":"1","author":"Del Ben","year":"2013","journal-title":"World J. Clin. Cases"},{"key":"B16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.genhosppsych.2019.05.005","article-title":"Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions","volume":"59","author":"Duman","year":"2019","journal-title":"Gen. Hosp. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1478-3231.2008.01716.x","article-title":"Bilirubin in clinical practice: a review","volume":"28","author":"Fevery","year":"2008","journal-title":"Liver Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1476-511X-9-146","article-title":"Lack of plasma albumin impairs intravascular lipolysis and explains the associated free fatty acids deficiency and hypertriglyceridemia","volume":"9","author":"Figueira","year":"2010","journal-title":"Lipids Health Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1542\/pir.2019-0134","article-title":"Seizures in children","volume":"41","author":"Fine","year":"2020","journal-title":"Pediatr. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1684\/epd.2022.1460","article-title":"Effect of long-term valproic acid therapy on lipid profiles in paediatric patients with epilepsy: a meta-analysis","volume":"24","author":"Guo","year":"2022","journal-title":"Epileptic Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/1381612825666190329145428","article-title":"Valproic acid and the liver injury in patients with epilepsy: an update","volume":"25","author":"Guo","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-0037-1600991","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.atherosclerosis.2017.09.034","article-title":"4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques","volume":"266","author":"Huang","year":"2017","journal-title":"Atherosclerosis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12020-010-9417-2","article-title":"Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population","volume":"39","author":"Jo","year":"2011","journal-title":"Endocrine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.seizure.2012.05.001","article-title":"Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy","volume":"21","author":"Kanemura","year":"2012","journal-title":"Seizure"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metabolism"},{"key":"B27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4103\/ijp.IJP_655_18","article-title":"The effect of long-term valproic acid treatment in the level of total cholesterol among adult","volume":"52","author":"Kusumastuti","year":"2020","journal-title":"Indian J. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/IJGM.S102819","article-title":"Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements","volume":"9","author":"Levitt","year":"2016","journal-title":"Int. J. Gen. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1111\/jcmm.14464","article-title":"Lipidomic characteristics and clinical findings of epileptic patients treated with valproic acid","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.seizure.2018.01.002","article-title":"Association between SCN1A gene polymorphisms and drug resistant epilepsy in pediatric patients","volume":"55","author":"Margari","year":"2018","journal-title":"Seizure"},{"key":"B31","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/0269881108091595","article-title":"Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial","volume":"23","author":"Martin","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2014.12.053","article-title":"Cross-sectional and longitudinal associations between serum bilirubin and dyslipidemia in a health screening population","volume":"239","author":"Oda","year":"2015","journal-title":"Atherosclerosis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1212\/CON.0000000000000707","article-title":"Epilepsy overview and revised classification of seizures and epilepsies","volume":"25","author":"Pack","year":"2019","journal-title":"Contin. (Minneap Minn)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.atherosclerosis.2016.02.006","article-title":"The prevalence, awareness, treatment and control of dyslipidemia among adults in China","volume":"248","author":"Pan","year":"2016","journal-title":"Atherosclerosis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/HCO.0000000000000249","article-title":"Dyslipidemia and cardiovascular changes in children","volume":"31","author":"Pires","year":"2016","journal-title":"Curr. Opin. Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/WCO.0000000000001144","article-title":"Recent advances in pharmacotherapy for epilepsy","volume":"36","author":"Pong","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/epi.17240","article-title":"International League against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Riney","year":"2022","journal-title":"Epilepsia"},{"key":"B38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.amjmed.2005.10.038","article-title":"A speculation about hypercholesterolemia in congenital analbuminemia","volume":"119","author":"Rosipal","year":"2006","journal-title":"Am. J. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.seizure.2017.03.007","article-title":"Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: a prospective study","volume":"48","author":"Sidhu","year":"2017","journal-title":"Seizure"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0153427","DOI":"10.1371\/journal.pone.0153427","article-title":"Bilirubin binding to PPAR\u03b1 inhibits lipid accumulation","volume":"11","author":"Stec","year":"2016","journal-title":"PloS one"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00381-012-1788-7","article-title":"Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate","volume":"28","author":"Tokgoz","year":"2012","journal-title":"Childs Nerv. Syst."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/j.1467-789X.2010.00800.x","article-title":"Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications","volume":"12","author":"Verrotti","year":"2011","journal-title":"Obes. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e004820","DOI":"10.1161\/JAHA.116.004820","article-title":"Bilirubin prevents atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice by inhibiting endothelial VCAM-1 and ICAM-1 signaling","volume":"6","author":"Vogel","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12874-021-01487-4","article-title":"The roles of predictors in cardiovascular risk models - a question of modeling culture?","volume":"21","author":"Wallisch","year":"2021","journal-title":"BMC Med. Res. Methodol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MED.0000000000000607","article-title":"Dyslipidemia in childhood and adolescence: from screening to management","volume":"28","author":"Yeung","year":"2021","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00228-020-02872-6","article-title":"Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis","volume":"76","author":"Yoon","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.3390\/nu14235174","article-title":"The effect of BMI on blood lipids and dyslipidemia in lactating women","volume":"14","author":"Yu","year":"2022","journal-title":"Nutrients"},{"key":"B50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40101-017-0134-x","article-title":"Anthropometric and metabolic indices in assessment of type and severity of dyslipidemia","volume":"36","author":"Zaid","year":"2017","journal-title":"J. Physiol. Anthropol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"890221","DOI":"10.3389\/fphar.2022.890221","article-title":"An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1349043\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T05:26:32Z","timestamp":1712035592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1349043\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":51,"alternative-id":["10.3389\/fphar.2024.1349043"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1349043","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"article-number":"1349043"}}